Allworth Financial LP Rani Therapeutics Holdings, Inc. Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 3,119 shares of RANI stock, worth $4,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,119
Previous 3,119
-0.0%
Holding current value
$4,148
Previous $11,000
45.45%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
35Shares Held
5.77MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.42 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$944,0710.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$656,4661.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$596,4940.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$402,6480.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $32.6M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...